$STBA

Raymond James assumes coverage on S&T Bancorp stock with Market Perform rating

Raymond James initiated coverage on S&T Bancorp (STBA) with a Market Perform rating, citing its strong banking franchise and disciplined credit practices. The company reported Q2 2026 earnings of $1.02 per share, exceeding expectations, with revenue of $105.24 million. STBA's net interest margin expanded to 3.99%, and it has raised its dividend for 13 consecutive years, currently yielding 3.06%. Analysts expect measured earnings growth and have revised estimates upwards.

Original reporting
Published Oct 1, 2026, 1:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STBA
Neutral
low confidence
Mentioned
$STBA
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$STBANeutralLow
01

Why it matters

The coverage note reiterates known performance metrics; no new material information is presented, limiting trading relevance.

02

Market read

Limited relevance; the article is a recap of already‑released earnings and analyst rating, offering little actionable insight.

03

What to watch

Potential future deposit growth and margin expansion are noted but not quantified in this article.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

Raymond James initiated coverage on S&T Bancorp with a Market Perform rating, citing deposit growth and margin expansion. The earnings figures quoted were already public from the July 23 release.

Company-level read

Ticker impact

$STBANeutralLow confidence
Context

Recap of S&T Bancorp's Q2 earnings and analyst coverage initiation, no new data beyond prior release.

Expected impact

neutral

Evidence & confidence

Since the earnings were disclosed on July 23, the market has already priced the results; the coverage note adds little incremental information.

Counterpoint

If investors believe the coverage upgrade signals undervaluation, a modest long position could be considered despite the recap nature.

Key entities

  • S&T Bancorp Inc.

    Regional bank (NASDAQ:STBA) subject of the coverage initiation.

  • Raymond James

    Equity research firm that initiated coverage.

Related articles

$STBAMed

S&T Bancorp (STBA) Q3 2026 Earnings Call Transcript

S&T Bancorp (STBA) reported Q3 2026 earnings with net interest margin expanding to 4.06% and revenue growth outpacing expense growth. Loan balances were flat, but average loan and deposit balances increased. Tangible book value per share rose to $29.28. The company maintained strong asset quality and expects continued margin expansion with potential rate increases. They plan to upgrade their mobile banking platform in Q4 and anticipate flat to low single-digit loan growth.

$STBAMed

S&T Bancorp Q3 Earnings Call Highlights

S&T Bancorp reported Q3 2026 with revenue growth outpacing expenses, improving efficiency ratio to 54.65%. Loan growth was modest, with commercial real estate up $65M but commercial and industrial down $50M. Deposits saw seasonal decline, but asset quality remained strong. The company paused share buybacks and expects low-single-digit asset growth. Management emphasized underwriting discipline and inorganic growth opportunities.

$STBAMed

S&T Bancorp (STBA) stock is up, what you need to know

S&T Bancorp (STBA) shares rose 4.1% after reporting Q3 2026 earnings of $1.09 per share, beating estimates. Revenue was $107.79M, up from $106.72M expected. Net income increased to $38.6M. The company cited higher loan yields and share buybacks as contributors to the growth. CEO Chris McComish highlighted record earnings and revenue. Shares traded at $51, near the 52-week high of $53.36.

$STBAMed

S&T Bancorp’s (NASDAQ:STBA) Q3 2026 sales beat estimates

S&T Bancorp (STBA) reported Q3 2026 sales exceeding estimates, with net interest income comprising 87.6% of total revenue over five years. TBVPS grew at 7% annually over five years but slowed to 5.9% recently. EPS beat expectations, while net interest income narrowly outperformed estimates. TBVPS slightly missed forecasts. The stock price remained unchanged at $48.86 post-results.